Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients

NCT: NCT07658040 · NOT_YET_RECRUITING

NCT IDNCT07658040
StatusNOT_YET_RECRUITING
Start Date2026-08-09
Completion2027-08-09
SponsorGainesville Eye Associates (OTHER)
First posted
Last updated

Brief Summary

This study is a prospective, randomized, two-arm, single-center, single-surgeon, double-masked (subject and assessor) comparative study. It involves bilateral implantation of intraocular lenses (IOLs), comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in normal cataract patients. The study will be conducted at one site and will include a pre-operative visit and a 3-month post-operative assessment.

Frequently Asked Questions

What is Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients?

Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients is a clinical trial registered under NCT07658040. Current status: NOT_YET_RECRUITING.

What is the status of NCT07658040?

The current status of NCT07658040 (Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients) is: NOT_YET_RECRUITING.

When did Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients start?

Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients started on 2026-08-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.